korumedical.com (KRMD) - Long-Term Liabilities to Capital

Corporate emblem and logo of KORU Medical (KRMD)

KORU Medical Systems (KRMD) aims to transition the therapy of rare pathologies to a home-based format by creating advanced portable injection devices. The business model relies on the high scalability of consumables production, which optimizes costs as volumes grow. This chart on GURU.Markets, where the indicator equals 0.15, complements data on drug delivery automation that minimizes the involvement of medical personnel in patient care.

KORU Medical - KRMD Long-Term Debt to Capital (period 07/04/2022 - 10/30/2026)

Comprehensive metric breakdowns and analytics for KORU Medical Systems, Inc. (KRMD)

- stock value and consensus price forecast:
Stock Quotes KORU Medical Systems Inc.|KRMD - Analyst Consensus Forecast
- market capitalization indicators:
Market Value KORU Medical|KRMD - Enterprise Value
- book value of equity indicators:
Equity per Share KORU Medical Systems|KRMD - Book Capitalization|Market Capitalization to Book Value korumedical.com|KRMD - Company Total Assets
- debt and solvency information:
Total Debt to Equity Ratio KORU Medical Systems|KRMD - Long-Term Debt to Capital|Short-Term Debt to Capital KORU Medical Systems Inc.|KRMD - Company Debts|Debt to Book Capitalization Ratio KORU Medical|KRMD - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings KORU Medical Systems|Interim Coverage Ratio korumedical.com
- financial results and valuation multiples details:
KRMD - Company Net Income
Comprehensive company analysis:korumedical.com
Signature product of KORU Medical Systems, Inc.

For a conservative investor, this ratio of long-term debt to equity serves as a measure of long-term solvency, determining the proportion of borrowed funds with a maturity of over one year within the equity structure. Low leverage, combined with the scalable sales model for infusion therapy consumables at KORU Medical Systems (KRMD), minimizes bankruptcy risk and confirms the stability of the financial foundation during business expansion.

Competing companies

Long-Term Debt to Equity Ratio Intuitive Surgical, Inc. (ISRG)|Long-Term Debt to Capital DHR|BDX - Long-Term Liabilities to Capital|Long-Term Debt to Capital STE (STERIS plc)|WST: Long-Term Debt to Capital Ratio|Baxter - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Masimo Corp MASI|STVN: Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Teleflex Corp|MMSI (Merit Medical Systems) - Long-Term Debt to Capital|Long-Term Debt to Capital envistaco.com|Long-Term Debt to Equity ICU Medical (ICUI)|Long-Term Debt to Equity XRAY (Dentsply Sirona Inc)|LeMaitre - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient ATRC|STAAR Surgical Company - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital ChromaDex Corp NAGE|ZimVie (ZIMV) - Long-Term Debt to Equity|Long-Term Debt to Capital Ratio ANGO|Long-Term Debt to Equity Cerus Corp|Teknova Inc (TKNO) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Ratio MGRM (Monogram Technologies)|Long-Term Loans to Capital Ratio STSS|Long-Term Debt to Equity InfuSystem Holdings, Inc. INFU|Long-Term Debt to Capital Coefficient UTMD|NYXH: Long-Term Debt to Equity Ratio|MBOT - Long-Term Debt to Capital|Pro-Dex, Inc. (PDEX) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio zentek.com|ELUT (Elutia) - Long-Term Debt to Capital|Long-Term Liabilities to Capital Milestone Scientific Inc MLSS|Long-Term Debt to Equity NEXGEL, Inc (NXGL)|retractable.com - Long-Term Debt to Capital Ratio|Harvard Bioscience, Inc. - Long-Term Debt to Equity Ratio|Long-Term Loans to Capital Ratio FEMY (femasys.com)|MHUA - Long-Term Debt to Equity|Ratio of Long-Term Indebtedness to Capital Predictive Oncology POAI|callanjmb.com (CJMB) - Long-Term Debt to Equity|Atrion Corporation Inc. (ATRI) - Long-Term Debt to Capital|Long-Term Debt to Equity NeuroMetrix, Inc.